Genome-wide association studies identify novel loci in rapidly progressive Alzheimer’s disease.

Recent data suggest that distinct prion-like amyloid beta and tau strains are associated with rapidly progressive Alzheimer’s disease (rpAD). The role of genetic factors in rpAD is largely unknown.